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Abstract
Porphyromonas gingivalis has been implicated as an important pathogen in the development of adult 
periodontitis, and its colonization of subgingival sites is critical in the pathogenic process. The gingipains are cell 
surface Arg- and Lys-specific proteinases of the bacterium Porphyromonas gingivalis, which has been associated 
with periodontitis, a disease that results in the destruction of the teeth-supporting tissues. The aim of this study 
was to investigate the efficacy of egg yolk antibody against gingipains (IgY-GP) to the protection alveolar bone 
loss by P. gingivalis in rats. Rats were orally infected with P. gingivalis ATCC 33277, which was suspended in 5% 
carboxymethylcellulose. Each rat received 0.5 ml of the suspension by oral gavage. Then, the IgY-GP and the IgY-
Control in 5% carboxymethylcellulose were administered, with each rat receiving 0.5 ml by oral gavage. The upper 
jaws were used as dry specimens for measuring horizontal alveolar bone loss. The distance between the cement-
enamel junction (CEJ) and the alveolar bone crest (ABC) was measured at 14 palatal sites per rat. P. gingivalis-
infected group showed an increased distance between CEJ and ABC compared to uninfected group, indicating 
an enhanced alveolar bone loss due to oral infection with P. gingivalis. However, administered the IgY-GP group 
showed a decreased distance between CEJ and ABC compared to P. gingivalis-infected group. The IgY-GP could 
be used for the development of passive immunization against P. gingivalis-associated periodontal disease. These 
findings suggested that the IgY-GP protects P. gingivalis–induced alveolar bone loss.
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溶液50 μ lと50 μ lの0.2 Mトリス塩酸緩衝液（pH 7.8）を
混和した反応溶液にP. gingivalis培養菌液の培養上清


































































































































P. g + IgY-GP
P. g + IgY-Control
図1　ラットによるP. gingivalis感染実験スケジュール
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P. g 100 100
P. g+IgY-GP 47.8 40.8
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